Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BIB
- Price
- 74.97
- Stock movement down
- -1.42 (-1.85%)
- Company name
- ProShares Ultra Nasdaq Biotechnology
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Market cap
- -
- Ent value
- -
- Price/Sales
- -
- Price/Book
- -
- Div yield
- 0.97%
- Div growth
- -
- Growth years
- 1
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 40.40%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-11-20
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
Dividend yield - 5y
Loading...
Dividend yield data
| Dividend per share | 0.72 |
| Dividend yield | 0.97% |
| Payout frequency | Quarterly |
| Maximum yield | 3.14% |
| Average yield | 1.38% |
| Minimum yield | 0.90% |
| Discount to avg yield | -43.22% |
| Upside potential | -30.18% |
| Yield as % of max yield | 30.79% |
Yield distribution (inverse percentile) - 5y
Loading...
Yield distribution data
| Dividend yield | 0.97% |
| Current yield distribution | 86.12% |
| Yield at 100% (Min) | 0.90% |
| Yield at 90% | 0.96% |
| Yield at 80% | 0.99% |
| Yield at 50% (Median) | 1.12% |
| Yield at 20% | 1.32% |
| Yield at 10% | 2.57% |
| Yield at 0% (Max) | 3.14% |
Dividend per share
Loading...
Dividend per share data
| Years of growth | 1 years |
| CCC status | - |
| Dividend per share | 0.72 |
| Payout frequency | Quarterly |
| Ex-div date | 24 Sep 2025 |
| EPS (TTM) | - |
| EPS (1y forward) | - |
| EPS growth (5y) | - |
| EPS growth (5y forward) | - |
Dividend growth
Loading...
Please create a free account or log in to access this chart
Dividend growth data
| BIB | S&P500 | |
| DGR MR | 38.17% | -13.74% |
| DGR TTM | 137.19% | 6.60% |
| DGR 3 years | - | 7.31% |
| DGR 5 years | - | 4.69% |
| DGR 10 years | - | 6.30% |
| DGR 15 years | - | 8.16% |
| Time since last change announced | 60 days |
| EPS growth (5y) | - |
| EPS growth (5y forward) | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 78.19 |
| Daily high | 79.34 |
| Daily low | 74.97 |
| Daily Volume | 25K |
| All-time high | 111.49 |
| 1y analyst estimate | - |
| Beta | 1.60 |
| EPS (TTM) | - |
| Dividend per share | 0.72 |
| Ex-div date | 24 Sep 2025 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BIB | S&P500 | |
| Current price drop from All-time high | -32.75% | -5.07% |
| Highest price drop | -66.82% | -19.00% |
| Date of highest drop | 8 Apr 2025 | 8 Apr 2025 |
| Avg drop from high | -50.96% | -2.73% |
| Avg time to new high | - | 6 days |
| Max time to new high | 281 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
-
Marketcap category
Description
The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
Employees
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page